ILM1 Medios AG
10.30EUR-0.58%Mkt Cap: 285.55M $P/E: 22.391d ago
Medios AG, together with its subsidiaries, supplies specialty pharmaceutical drugs primarily in Germany. It operates through three segments: Patient-Specific Therapies; International Business; and Pharmaceutical Supply. …
Industry Peers
Medical DistributionKey Statistics
Company
Market Cap285.55M USD
Enterprise Value401.59M USD
Revenue (TTM)2.35B USD
Gross Profit216.49M USD
Net Income (TTM)16.70M USD
Revenue/Share88.06 EUR
Last Price10.30 EUR
Fiscal Year EndDec 2025
MR QuarterJun 2026
Employees989
CountryDE
SectorHealthcare
IndustryMedical Distribution
ISINDE000A1MMCC8
Valuation
P/E (Trailing)22.39
P/E (Forward)6.82
PEG—
EV/EBITDA5.30
EV/Revenue0.17
P/S0.12
P/B0.49
EPS (TTM)0.46
EPS (Forward)1.52
52W Range
9.9804% of range17.44
52W High17.44 EUR
52W Low9.980 EUR
Profitability
Gross Margin9.58%
Oper. Margin1.64%
EBITDA Margin3.22%
Profit Margin0.74%
ROE2.99%
ROA1.70%
Growth
Revenue Growth8.00%
Earnings Growth-41.50%
Cash Flow & Leverage
Operating CF56.82M USD
CapEx (TTM)9.01M USD
FCF Margin1.06%
FCF Yield8.76%
Net Debt125.48M USD
Net Debt/EBITDA1.66
Balance Sheet
Debt/Equity0.37
Current Ratio1.84
Quick Ratio1.30
Book Value/Sh21.35 EUR
Cash/Share3.45 EUR
Dividends
Fwd Div Rate—
Trail. Div Rate0.00 EUR
Div. Yield0.00%
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Splits
Last Split1:4
Split DateJul 19, 2012
Analyst Consensus
Rating1.0 (Strong Buy)
Strong BuyBuyHoldSellStr. Sell
Target (Mean)20.25 EUR
Upside (mean)+96.6%
Target Range16.00 EUR – 23.00 EUR
16.00+96.6% to mean23.00
# Analysts4
Ownership
Shares Out.25.51M
Float14.33M
Insiders19.70%
Institutions47.72%
Technical
SMA 5010.89 (-5.4%)
SMA 20013.17 (-21.8%)
Beta1.30
S&P 52W Chg14.58%
Avg Vol (30d)37.57K
Avg Vol (10d)47.63K
Technical Indicators
RSI (14)41.8
MACD-0.0659
MACD Signal-0.1091
MACD Hist.+0.0432
BB Upper11.27 EUR
BB Middle10.51 EUR
BB Lower9.745 EUR
BB Width14.54%
ATR (14)0.4179 EUR
Vol Ratio (20d)5.20x